Skip to main content
. 2014 Oct 15;1(10):634–648. doi: 10.18632/oncoscience.87

Figure 3. Comparison of stromal versican and biglycan expression in DCIS lesions with sclerotic or myxoid stroma.

Figure 3

(A) Bar chart displaying the relation between stromal versican expression and stromal architecture. Despite a trend toward high versican expression in DCIS with myxoid stroma, statistical significance was not reached (p=0.181), due to lack of power (β=0.803). (B) Photomicrograph displaying high periductal versican immunoreactivity (arrow) in a DCIS lesion with myxoid stroma. Original magnification 100x. (C) Bar chart illustrating the absence of any association (p=0.325) between stromal biglycan expression and stromal architecture. (D) Photomicrograph illustrating high periductal biglycan staining (arrow) in a DCIS lesion with myxoid stroma. Original magnification 100x.